PTC Therapeutics
PTCTPTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.In September 2009, PTC entered into an agreement with R …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at PTC Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/2/2024 | Sell | Golden, Lee Scott | EVP & CHIEF MEDICAL OFFICER | $28.4 | $14,923 |
| 1/30/2024 | Sell | Utter, Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | $27.3 | $8,666 |
| 1/30/2024 | Sell | Pauwels, Eric | CHIEF BUSINESS OFFICER | $27.3 | $9,974 |
| 1/30/2024 | Sell | Boulding, Mark Elliott | EXEC. VP AND CLO | $27.3 | $21,637 |
| 1/30/2024 | Sell | Almstead, Neil Gregory | CHIEF TECHNICAL OPS OFFICER | $27.3 | $17,604 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)